In Figure 6E , higher PDCD1 expression was associated with a better prognosis, although the difference did not reach statistical significance (21.9 vs . 25.9 months, P = 0.064).
← all excerpts
Prognostic modeling of early-onset nondistal gastric cancer identifies <i>ARSB-PDCD1</i> ratio as an immune-related survival stratifier.
1
0.0640
0.0640